J. Craig Venter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
J. Craig Venter has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Dana Busam
J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850
2 shared publicationsKelvin Li
J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850
2 shared publicationsSteve Ferriera
J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850
2 shared publicationsAaron Halpern
J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850
1 shared publicationAlexia Tsiamouri
Department of Neurosurgery, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Baltimore, MD 21224; ‡J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850; §San Diego Supercomputer Center, 9500 Gilman Drive, La Jolla, CA 92093; ¶Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205; and ∥Ludwig Institute for Cancer Research, 605 Third Avenue, New York, NY 10158
1 shared publication- Andrew F. Neuwald
Institute for Genome Sciences and Department of Biochemistry & Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
1 shared publication
Latest Publications
- Open Access
- 19 May 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (5) , R52
Towards a comprehensive structural variation map of an individual human genome
Background: Several genomes have now been sequenced, with millions of genetic variants annotated. While significant progress has been made in mapping single nucleotide polymorphisms (SNPs) and small (24% of structural variants would not be imputed by SNP-association. Conclusions: Our results indicate that a large number of structural variants have been unreported in the individual genomes published to date. This significant extent and complexity of structural variants, as well as the growing recognition of their medical relevance, necessitate they be actively studied in health-related analyses of personal genomes. The new catalogue of structural variants generated for this genome provides a crucial resource for future comparison studies.
- 19 May 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (5) , R52
Open AccessTowards a comprehensive structural variation map of an individual human genome
Background: Several genomes have now been sequenced, with millions of genetic variants annotated. While significant progress has been made in mapping single nucleotide polymorphisms (SNPs) and small (24% of structural variants would not be imputed by SNP-association. Conclusions: Our results indicate that a large number of structural variants have been unreported in the individual genomes published to date. This significant extent and complexity of structural variants, as well as the growing recognition of their medical relevance, necessitate they be actively studied in health-related analyses of personal genomes. The new catalogue of structural variants generated for this genome provides a crucial resource for future comparison studies.
- Open Access
- 12 December 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (12) , R264
Evolution of allostery in the cyclic nucleotide binding module
Background: The cyclic nucleotide binding (CNB) domain regulates signaling pathways in both eukaryotes and prokaryotes. In this study, we analyze the evolutionary information embedded in genomic sequences to explore the diversity of signaling through the CNB domain and also how the CNB domain elicits a cellular response upon binding to cAMP. Results: Identification and classification of CNB domains in Global Ocean Sampling and other protein sequences reveals that they typically are fused to a wide variety of functional domains. CNB domains have undergone major sequence variation during evolution. In particular, the sequence motif that anchors the cAMP phosphate (termed the PBC motif) is strikingly different in some families. This variation may contribute to ligand specificity inasmuch as members of the prokaryotic cooA family, for example, harbor a CNB domain that contains a non-canonical PBC motif and that binds a heme ligand in the cAMP binding pocket. Statistical comparison of the functional constraints imposed on the canonical and non-canonical PBC containing sequences reveals that a key arginine, which coordinates with the cAMP phosphate, has co-evolved with a glycine in a distal β2-β3 loop that allosterically couples cAMP binding to distal regulatory sites. Conclusion: Our analysis suggests that CNB domains have evolved as a scaffold to sense a wide variety of second messenger signals. Based on sequence, structural and biochemical data, we propose a mechanism for allosteric regulation by CNB domains.
- 12 December 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (12) , R264
Open AccessEvolution of allostery in the cyclic nucleotide binding module
Background: The cyclic nucleotide binding (CNB) domain regulates signaling pathways in both eukaryotes and prokaryotes. In this study, we analyze the evolutionary information embedded in genomic sequences to explore the diversity of signaling through the CNB domain and also how the CNB domain elicits a cellular response upon binding to cAMP. Results: Identification and classification of CNB domains in Global Ocean Sampling and other protein sequences reveals that they typically are fused to a wide variety of functional domains. CNB domains have undergone major sequence variation during evolution. In particular, the sequence motif that anchors the cAMP phosphate (termed the PBC motif) is strikingly different in some families. This variation may contribute to ligand specificity inasmuch as members of the prokaryotic cooA family, for example, harbor a CNB domain that contains a non-canonical PBC motif and that binds a heme ligand in the cAMP binding pocket. Statistical comparison of the functional constraints imposed on the canonical and non-canonical PBC containing sequences reveals that a key arginine, which coordinates with the cAMP phosphate, has co-evolved with a glycine in a distal β2-β3 loop that allosterically couples cAMP binding to distal regulatory sites. Conclusion: Our analysis suggests that CNB domains have evolved as a scaffold to sense a wide variety of second messenger signals. Based on sequence, structural and biochemical data, we propose a mechanism for allosteric regulation by CNB domains.
- 29 September 2006
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 313 (5795) , 1892
An Ointment for the Fly
Won for All. How the Drosophila Genome Was Sequenced. By Michael Ashburner. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2006. 123 pp. $19.95, £11. ISBN 0-87969-802-0. The author offers a short, lively account (almost resembling diary extracts) of the collaborative effort that sequenced the Drosophila genome.
- 29 September 2006
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 313 (5795) , 1892
An Ointment for the Fly
Won for All. How the Drosophila Genome Was Sequenced. By Michael Ashburner. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2006. 123 pp. $19.95, £11. ISBN 0-87969-802-0. The author offers a short, lively account (almost resembling diary extracts) of the collaborative effort that sequenced the Drosophila genome.
- 25 July 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (30) , 11240-11245
A Sanger/pyrosequencing hybrid approach for the generation of high-quality draft assemblies of marine microbial genomes
Since its introduction a decade ago, whole-genome shotgun sequencing (WGS) has been the main approach for producing cost-effective and high-quality genome sequence data. Until now, the Sanger sequencing technology that has served as a platform for WGS has not been truly challenged by emerging technologies. The recent introduction of the pyrosequencing-based 454 sequencing platform (454 Life Sciences, Branford, CT) offers a very promising sequencing technology alternative for incorporation in WGS. In this study, we evaluated the utility and cost-effectiveness of a hybrid sequencing approach using 3730 xl Sanger data and 454 data to generate higher-quality lower-cost assemblies of microbial genomes compared to current Sanger sequencing strategies alone.
- 25 July 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (30) , 11240-11245
A Sanger/pyrosequencing hybrid approach for the generation of high-quality draft assemblies of marine microbial genomes
Since its introduction a decade ago, whole-genome shotgun sequencing (WGS) has been the main approach for producing cost-effective and high-quality genome sequence data. Until now, the Sanger sequencing technology that has served as a platform for WGS has not been truly challenged by emerging technologies. The recent introduction of the pyrosequencing-based 454 sequencing platform (454 Life Sciences, Branford, CT) offers a very promising sequencing technology alternative for incorporation in WGS. In this study, we evaluated the utility and cost-effectiveness of a hybrid sequencing approach using 3730 xl Sanger data and 454 data to generate higher-quality lower-cost assemblies of microbial genomes compared to current Sanger sequencing strategies alone.
- 1 June 2006
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (6) , 657-658
Single-cell genomics
- 1 June 2006
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (6) , 657-658
Single-cell genomics
- 30 September 2005
- Published by Elsevier in Trends in Microbiology
- Vol. 13 (9) , 404
Taking metagenomic studies in context
- 30 September 2005
- Published by Elsevier in Trends in Microbiology
- Vol. 13 (9) , 404
Taking metagenomic studies in context
- 26 September 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (40) , 14344-14349
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas
It is now clear that tyrosine kinases represent attractive targets for therapeutic intervention in cancer. Recent advances in DNA sequencing technology now provide the opportunity to survey mutational changes in cancer in a high-throughput and comprehensive manner. Here we report on the sequence analysis of members of the receptor tyrosine kinase (RTK) gene family in the genomes of glioblastoma brain tumors. Previous studies have identified a number of molecular alterations in glioblastoma, including amplification of the RTK epidermal growth factor receptor. We have identified mutations in two other RTKs: (i) fibroblast growth receptor 1, including the first mutations in the kinase domain in this gene observed in any cancer, and (ii) a frameshift mutation in the platelet-derived growth factor receptor-α gene. Fibroblast growth receptor 1, platelet-derived growth factor receptor-α, and epidermal growth factor receptor are all potential entry points to the phosphatidylinositol 3-kinase and mitogen-activated protein kinase intracellular signaling pathways already known to be important for neoplasia. Our results demonstrate the utility of applying DNA sequencing technology to systematically assess the coding sequence of genes within cancer genomes.
- 26 September 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (40) , 14344-14349
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas
It is now clear that tyrosine kinases represent attractive targets for therapeutic intervention in cancer. Recent advances in DNA sequencing technology now provide the opportunity to survey mutational changes in cancer in a high-throughput and comprehensive manner. Here we report on the sequence analysis of members of the receptor tyrosine kinase (RTK) gene family in the genomes of glioblastoma brain tumors. Previous studies have identified a number of molecular alterations in glioblastoma, including amplification of the RTK epidermal growth factor receptor. We have identified mutations in two other RTKs: (i) fibroblast growth receptor 1, including the first mutations in the kinase domain in this gene observed in any cancer, and (ii) a frameshift mutation in the platelet-derived growth factor receptor-α gene. Fibroblast growth receptor 1, platelet-derived growth factor receptor-α, and epidermal growth factor receptor are all potential entry points to the phosphatidylinositol 3-kinase and mitogen-activated protein kinase intracellular signaling pathways already known to be important for neoplasia. Our results demonstrate the utility of applying DNA sequencing technology to systematically assess the coding sequence of genes within cancer genomes.